COVID-19: government calls for accelerating pace of second vaccination recall in face of resumption

The health authorities consider “insufficient” the rate of the second recall, less than 2.2 million have been injected, out of more than 8.7 million eligible people.

Le Monde

A quarter of eligible people received their second vaccination recall against COVVI-19, a rate “clearly insufficient” according to the government, which called on Tuesday, June 21, the oldest to receive “fastest injection” Possible “, while” moderate epidemic recovery “begins. “It is not going fast enough, there are not enough people who come to be vaccinated,” worried the Ministry of Health during a press point.

To date, less than 2.2 million second reminders have been injected, on more than 8.7 million eligible people – mainly over 60s, as well as immunocompromised. However, with almost 200,000 “fourth doses”, the past week has been the most prolific since the launch of the campaign in mid-March. But the six -month rule since the first recall has the eligible population swells in parallel, which will exceed nine million in early July.

live concern among residents of nursing homes

concern is particularly lively in residents of nursing homes (48 % vaccinated eligible) and other people over 80 years old (31 %), who must “be vaccinated as quickly as possible to pass the summer and fall serenely, “insisted the ministry.

Also pointing “clearly insufficient vaccination rates”, the P r Alain Fischer, president of the guidance council of the vaccination strategy, stressed that the “significant reduction” of the protection generated By the first recall “fully justifies” a new dose in the older ones to “protect them from serious forms until the fall”.

Especially since the “moderate epidemic recovery” observed in recent weeks (the number of cases has more than doubled in three weeks) “is accompanied by a small resumption of hospitalizations” and risks training “a Incredible increase in time “of critical care entrances and deaths, he noted. All the more reason not to wait for the new vaccines -in particular, those of Pfizer, Moderna, Sanofi and Hipra, he said -even if “the ideal would be that they are available at the time of The antigrippale campaign “for a new reminder at the end of the year.

/Media reports.